Pharma-Natural recalls

Pharma-Natural has 17 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 4 Oct 2023. The most frequent reason is potency & assay.

Total recalls17since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 4 Oct 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 16 94%Class III 1 6%

Why pharma-natural is recalled

Potency & Assay1694%
Other Reasons16%

Product types

Brands

By year

202316%
20191694%

All pharma-natural recalls, newest first

17 total

Reported	Class	Recall	Company	Reason	Where
4 Oct 2023Food	CLASS III	Pharma Natural, Biotin 5000 mcg, Maximum Strength recalledPharma	Pharma-Natural	Other	PR
31 Jul 2019Drug	CLASS II	Army Health With Curcumin (Menthol 00%) Pain Reliever recalled	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Oliver's Harvest CBD+Capsaicin 2% Pain Relief recalled by Pharma-Natural	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Dermanak original crema blanqueador recalled by Pharma-Natural	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Neogen-d (Dextromethorphan HBr, 30 mg recalled by Pharma-Natural	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Lido E.R. (Lidocaine HCL 4%) Pain Relieving Topical Analgesic Cream recalled	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Tusslin (Dextromethorphan HBr, 28 mg recalled by Pharma-Natural	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Lid O Creme (Lidocaine HCL recalled by Pharma-Natural	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Oliver's Harvest CBD+Lidocaine HCL 4% Pain Relief recalled	Pharma-Natural	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	LidoAID (Lidocaine HCL 4%) portable pain relieving Topical recalled	Pharma-Natural	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.